Valve sparing root replacement in children with connective tissue disease: long-term risk of aortic events.

BACKGROUND: Cardiovascular involvement in pediatric patients with connective tissue disease (CTD) is life-threatening, with aortic root dilatation being the most prevalent cardiovascular abnormality. We attempted to determine long-term outcomes of valve-sparing root replacement (VSRR) in this group, including cardiovascular reoperations for aortic aneurysm and dissection.

METHODS: We conducted a retrospective analysis of pediatric patients with CTD, who received VSRR in a single center from 2002 to 2021. The primary endpoint was a composite event of all-cause death and cardiovascular reoperations. The median follow-up duration was 8.3 years, with a maximum of 20.7 years.

RESULTS: The median age of 24 pediatric patients who had VSRR was 14.4 years. Marfan syndrome and Loeys-Dietz syndrome affected 19 (79.2%) and 5 (20.8%) patients, respectively. There was no early death. And the 15-year survival rate was 91.7%. At 10 years after VSRR, the cumulative incidence of reoperation for aortic regurgitation (AR) was 15.6%, and for aortic aneurysm or dissection, it was 29.1%. The 10-year rate of freedom from the primary endpoint was 53.1%. The Cox multivariable analysis revealed younger age at surgery (hazard ratio [HR], 1.279; 95% confidence interval [CI] 1.086-1.505; P = .003) and VSRR before 13 years of age (HR, 5.005; 95% CI 1.146-21.850; P = .032) as independent prognostic factors for the primary endpoint.

CONCLUSIONS: VSRR for aortic root dilatation in pediatric patients with CTD demonstrated good long-term survival and low reoperation rates for AR. However, several patients developed later aortic aneurysm or dissection, and careful surveillance may be required, particularly in those who received VSRR at younger age.